XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Additional Pain In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Balance at Dec. 31, 2020 $ 109,827 $ 2 $ 216,126 $ (106,325) $ 24
Balance, shares at Dec. 31, 2020   19,677,249      
Issuance of common stock upon exercise of stock options 976   976    
Issuance of common stock upon exercise of stock options, shares   393,991      
Issuance of common stock related to financing 143,754 $ 1 143,753    
Issuance of common stock related to financing, shares   11,729,353      
Exercise of warrant, shares   1,806      
Stock-based compensation expense 3,043   3,043    
Net income (21,319)     (21,319)  
Other comprehensive loss (22)       (22)
Balance at Mar. 31, 2021 236,259 $ 3 363,898 (127,644) 2
Balance, shares at Mar. 31, 2021   31,802,399      
Balance at Dec. 31, 2020 109,827 $ 2 216,126 (106,325) 24
Balance, shares at Dec. 31, 2020   19,677,249      
Net income (32,173)        
Balance at Jun. 30, 2021 228,341 $ 3 366,836 (138,498)  
Balance, shares at Jun. 30, 2021   31,842,002      
Balance at Mar. 31, 2021 236,259 $ 3 363,898 (127,644) 2
Balance, shares at Mar. 31, 2021   31,802,399      
Issuance of common stock upon exercise of stock options 279   279    
Issuance of common stock upon exercise of stock options, shares   39,603      
Stock-based compensation expense 2,659   2,659    
Net income (10,854)     (10,854)  
Other comprehensive loss (2)       $ (2)
Balance at Jun. 30, 2021 228,341 $ 3 366,836 (138,498)  
Balance, shares at Jun. 30, 2021   31,842,002      
Balance at Dec. 31, 2021 303,129 $ 4 471,449 (168,324)  
Balance, shares at Dec. 31, 2021   39,736,914      
Issuance of common stock upon exercise of stock options 93   93    
Issuance of common stock upon exercise of stock options, shares   10,099      
Issuance of common stock upon vesting of restricted stock, shares   224,000      
Stock-based compensation expense 4,350   4,350    
Net income 4,618     4,618  
Shares withheld for taxes (1,106)   (1,106)    
Shares withheld for taxes, shares   (85,197)      
Balance at Mar. 31, 2022 311,084 $ 4 474,786 (163,706)  
Balance, shares at Mar. 31, 2022   39,885,816      
Balance at Dec. 31, 2021 $ 303,129 $ 4 471,449 (168,324)  
Balance, shares at Dec. 31, 2021   39,736,914      
Issuance of common stock upon exercise of stock options, shares 27,953        
Net income $ (17,920)        
Balance at Jun. 30, 2022 293,267 $ 4 479,507 (186,244)  
Balance, shares at Jun. 30, 2022   40,020,755      
Balance at Mar. 31, 2022 311,084 $ 4 474,786 (163,706)  
Balance, shares at Mar. 31, 2022   39,885,816      
Issuance of common stock upon exercise of stock options 183   183    
Issuance of common stock upon exercise of stock options, shares   17,854      
Purchase of common stock under ESPP 203   203    
Purchase of common stock under ESPP Shares   16,354      
Exercise of warrant, shares   100,731      
Stock-based compensation expense 4,335   4,335    
Net income (22,538)     (22,538)  
Balance at Jun. 30, 2022 $ 293,267 $ 4 $ 479,507 $ (186,244)  
Balance, shares at Jun. 30, 2022   40,020,755